DR JOHN HOLT'S UHF TREATMENT – COLORECTAL CANCER TRIAL : AN HYPOTHESIS

An “Once-in-a-lifetime” clinical trial seeking an improved survival for patients with rectal cancer, compared standard radiotherapy (RT) and RT+ Radio wave (UHF) irradiation at 434 MHz. Whilst no significant difference was recorded, the Kaplan-Meier graphs revealed a trend towards a worsening of the RT+UHF treatment arm. This, and more recent research findings, gives insight into possible UHF stimulatory effects on some cancers. Conclusion: UHF applied to patients with cancers carrying some mutations of the APC gene may stimulate cancer.